Cargando…
Targeting the A2A adenosine receptor counteracts immunosuppression in vivo in a mouse model of chronic lymphocytic leukemia
Tumor immunosuppression is a major cause of treatment failure and disease relapse, both in solid tumors and leukemia. Local hypoxia is among the conditions that cause immunosuppression, acting at least in part through the upregulation of extracellular adenosine levels, which potently suppress T-cell...
Autores principales: | Arruga, Francesca, Serra, Sara, Vitale, Nicoletta, Guerra, Giulia, Papait, Andrea, Gyau, Benjamin Baffour, Tito, Francesco, Efremov, Dimitar, Vaisitti, Tiziana, Deaglio, Silvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094100/ https://www.ncbi.nlm.nih.gov/pubmed/32299906 http://dx.doi.org/10.3324/haematol.2019.242016 |
Ejemplares similares
-
Immune Response Dysfunction in Chronic Lymphocytic Leukemia: Dissecting Molecular Mechanisms and Microenvironmental Conditions
por: Arruga, Francesca, et al.
Publicado: (2020) -
Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche?
por: Vaisitti, Tiziana, et al.
Publicado: (2018) -
Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets
por: Vaisitti, Tiziana, et al.
Publicado: (2019) -
Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia
por: Vitale, Candida, et al.
Publicado: (2023) -
The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies
por: Arruga, Francesca, et al.
Publicado: (2018)